A Study to Evaluate the Effects of Mavacamten in Healthy Participants

Status:
Not yet recruiting

Trial end date:
2023-07-15

Target enrollment:

Participant gender:

The purpose of the study is to evaluate the effect between two different single doses of mavamten in healthy participants.

Phase 1

Bristol-Myers Squibb